Skip to main content
OpenTrials
Completed

NCT Number: NCT07638020

Effect of a Village Doctor-delivered Exercise Therapy for Knee Osteoarthritis

The goal of this clinical trial is to test the feasibility of village doctor-delivered exercise therapy for knee osteoarthritis in rural China, and to preliminarily explore its treatment effects. The main questions it aims to answer are:

1. Is the exercise therapy delivered by village doctors feasible with satisfactory participant adherence? 2. Can this intervention produce preliminary benefits in this small pilot sample? Researchers will compare village doctor-delivered exercise therapy to usual care to see if the intervention leads to greater pain relief and functional improvement in this pilot study.

Participants will complete village-delivered exercise therapy three times a week for 12 weeks, then maintain independent exercise for another 12 weeks or receive usual care for a total of 24 weeks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Xiangya Hospital, Central South University

Changsha, Hunan, 410008, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged 50-80 years;
  • clinically diagnosed KOA according to the National Institute for Health and Care Excellence clinical criteria for OA (aged ≥45 years, activity-related knee pain, and either no morning joint-related stiffness or morning stiffness lasting no longer than 30 minutes);
  • knee pain occurring on most days for over three months;
  • the VAS pain score (range 0-10) ≥4;
  • Kellgren-Lawrence (KL) grade of 2-3;
  • residency in the designated village for the study duration.

Exclusion criteria

  • have received intra-articular knee injections for pain within the past six months;
  • have a history of knee surgery or have a planned knee replacement;
  • have rheumatoid arthritis or other inflammatory joint diseases;
  • possess physical or mental comorbidity that could interfere with the exercise regimen;
  • have engaged in regular or organized exercise therapy within the past six months;
  • are involved in an ongoing clinical trial

Treatment and study plan

Exercise

Behavioral

The village doctor-delivered exercise program will be conducted over 12 weeks, with participants engaging in three sessions per week, each lasting approximately 50 minutes. To prevent excessive fatigue, each session will be scheduled with at least a one-day interval. Each session will consist of three phases: a warm-up phase, an exercise phase, and a cool-down phase. Following the 12-week exercise program supervised by village doctors, participants in the intervention group will be encouraged by researchers and village doctors to continue the exercise program without supervision until the 24-week follow-up.

Usual Care

Behavioral

Participants will seek medical attention and address their knee pain issues according to their past habits, but should not increase the use of previously unused treatment methods or adopt invasive treatment methods during the study period.

Primary outcomes

  1. Visual Analogue Scale (VAS) of pain

    Time frame: From baseline to 12-week follow-up

    Changes in VAS pain score (range 0-10, with higher scores indicating greater pain) from baseline to 12-week follow-up

  2. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function score

    Time frame: From baseline to 12-week follow-up

    Changes in WOMAC function score (range 0-68, with higher score indicating more dysfunction) from baseline to 12-week follow-up

Secondary outcomes

  1. Visual Analogue Scale (VAS) of pain

    Time frame: From baseline to 6-week and 24-week follow-ups

    Changes in VAS pain score (range 0-10, with higher scores indicating greater pain) from baseline to 6-week and 24-week follow-ups

  2. WOMAC function score

    Time frame: From baseline to 6-week and 24-week follow-ups

    Changes in WOMAC function score (range 0-68, with higher score indicating more dysfunction) from baseline to 6-week and 24-week follow-ups

  3. WOMAC pain score

    Time frame: From baseline to 6-week, 12-week, and 24-week follow-ups

    Changes in WOMAC pain score (ranges from 0 to 20, with higher scores indicating greater pain) from baseline to 6-week, 12-week, and 24-week follow-ups

  4. WOMAC stiffness score

    Time frame: From baseline to 6-week, 12-week, and 24-week follow-ups

    Changes in WOMAC stiffness score (range 0-8, with higher score indicating more stiffness) from baseline to 6-week, 12-week, and 24-week follow-ups

  5. WOMAC total score

    Time frame: From baseline to 6-week, 12-week, and 24-week follow-ups

    Changes in total WOMAC score (0-96, with higher score indicating worse symptoms and function) from baseline to 6-week, 12-week, and 24-week follow-ups

  6. Patient global assessment (PGA)

    Time frame: From baseline to 6-week, 12-week, and 24-week follow-ups

    Changes in PGA score (range 0-10, with higher score indicating worse knee condition) from baseline to 6-week, 12-week, and 24-week follow-ups

  7. 12-Item Short Form Health Survey (SF-12)

    Time frame: From baseline to 6-week, 12-week, and 24-week follow-ups

    Changes in SF-12 score from baseline to 6-week, 12-week, and 24-week follow-ups. The SF-12 includes 12 items covering eight health domains and generates Physical Component Summary (PCS) and Mental Component Summary (MCS) scores on a 0-100 scale, with higher scores indicating better health-related quality of life

  8. Knee synovitis

    Time frame: From baseline to 12-week follow-up

    Changes in knee synovitis (measured by ultrasound) from baseline to 12-week follow-up

  9. Short Physical Performance Battery (SPPB)

    Time frame: From baseline to 12-week follow-up.

    Changes in SPPB score (range 0-12, with higher score indicating better physical performance) from baseline to 12-week follow-up

  10. Timed Up and Go (TUG) test

    Time frame: From baseline to 12-week follow-up

    Changes in TUG test from baseline to 12-week follow-up. The TUG test measures the time, in seconds, it takes for an individual to perform the following sequence of actions: stand up from a standard armchair (approximately 46 cm in seat height), walk a distance of 3 meters, turn, walk back to the chair, and sit down again. During the test, the participant wears their regular footwear and may use their customary walking aid, which can include none, a cane, or a walker. No physical assistance is provided. Fastest of two trials is recorded in seconds

  11. 30s chair stand test

    Time frame: From baseline to 12-week follow-up

    Changes in 30s chair stand test from baseline to 12-week follow-up. For the 30s chair stand test, participants are asked to fold their arms across their chest and to stand up from the chair one time. If successful, participants will be asked to stand up and sit down within 30 seconds as quickly as possible. The total number of stands executed correctly within 30s is recorded.

  12. 6-meter walking test

    Time frame: From baseline to 12-week follow-up

    Changes in 6-meter walking test from baseline to 12-week follow-up. In the 6-meter walking test, we measure the time it took to walk 6 meters at a regular pace, starting from a moving position, without slowing down, and then calculate the average of 2 tests.

  13. Muscle thickness of quadriceps muscle

    Time frame: From baseline to 12-week follow-up

    Changes in muscle thickness of quadriceps muscle (measured by ultrasound) from baseline to 12-week follow-up

  14. Muscle quality of quadriceps muscle

    Time frame: From baseline to 12-week follow-up

    Changes in muscle quality of quadriceps muscle (measured by ultrasound) from baseline to 12-week follow-up

  15. Grip strength

    Time frame: From baseline to 12-week follow-up

    Changes in grip strength from baseline to 12-week follow-up. Grip strength is measured using a calibrated JAMAR hydraulic hand dynamometer (Lafayette Instruments). Participants are positioned sitting upright in a stable four-legged chair (no armrests) with thighs horizontal and at 90°. The assessed arm is bent with the upper arm vertical, lower arm horizontal, elbow tight into the waist and the non-assessed arm placed relaxed in their lap. Three measurements are taken at 10-second intervals for each hand and the averaged value of the three measurements is used as the final grip strength for each hand

  16. Quadriceps muscle strength

    Time frame: From baseline to 12-week follow-up

    Changes in quadriceps muscle strength from baseline to 12-week follow-up. The maximum voluntary quadriceps contraction is assessed for each participant in a standard fashion using the 'Nicholas Manual Muscle Tester' (Lafayette Instruments). The participant is positioned sitting upright on a stable flat surface (no arm rests) with thighs horizontal and knees at 90° flexion. The instrument is then positioned at the bottom of the participant's tibia just above the ankle and they are asked to push against it as hard as possible in an attempt to raise their lower leg forwards, with resistance provided by the research metrologist. This is carried out three times on each leg and the mean value for each side is recorded

  17. Hamstring muscle strength

    Time frame: From baseline to 12-week follow-up

    Changes in hamstring muscle strength from baseline to 12-week follow-up. The maximum voluntary hamstrings muscle strength is assessed for each participant in a standard fashion using the 'Nicholas Manual Muscle Tester' (Lafayette Instruments). Participants are tested in prone for three repetitions with the test knee at 90° flexion and with the dynamometer placed immediately proximal to the level of the prominence of the lateral malleolus. Tests are performed alternating between the dominant and non-dominant limb. The mean value of three testing for each side is recorded

  18. Quantitative sensory testing (QST)

    Time frame: From baseline to 12-week follow-up

    Changes in QST from baseline to 12-week follow-up. Pressure pain threshold (PPT) is assessed to represent quantitative sensory. An algometer (1 cm2 rubber tip; Wagner, FDIX25) is applied at a rate of 0.5 kg/second on each anatomical site and determining the point at which participants verbally indicated the pressure first changed to slight pain. Participants are familiarised before testing by twice PPT testing on sternal notch. The PPT testing is conducted at 9 sites: sternum (3-cm caudal to the sternal notch), the medial and lateral tibiofemoral joint lines adjacent to the patellar ligament of each knee, the proximal tibia (5-cm distal to the tibial tuberosity of each leg), and the centre of the patella

  19. Hip abductor muscle strength

    Time frame: From baseline to 12-week follow-up

    Changes in hip abductor muscle strength from baseline to 12-week follow-up. The maximum voluntary hip abductor muscle contraction is assessed for each participant in a standard fashion using the 'Nicholas Manual Muscle Tester' (Lafayette Instruments). The participant is positioned on a clinic couch lying on their side with the lower leg bent for stability and the upper leg out straight. The instrument is then positioned above the lateral condyle of femur and the participant are asked to push against it as hard as possible in an attempt to raise their leg up towards the ceiling with resistance provided by the researcher. This is carried out three times on each leg and the mean value for each side is recorded

  20. Appendicular skeletal muscle mass

    Time frame: From baseline to 12-week follow-up

    Changes in appendicular skeletal muscle mass from baseline to 12-week follow-up. The participant had their appendicular skeletal muscle mass measured using bioimpedance analyses (InBody 770 analyser, InBody Japan, Tokyo, Japan). With bare feet, the participants are instructed to stand with heel and forefoot placed on the metal plates of the instrument and grab the handle. A sub-threshold electrical current is then transmitted through the body from foot to foot. The impedance-based appendicular skeletal muscle mass is determined as per the manufacturer's imbedded equations

  21. Body fat percentage

    Time frame: From baseline to 12-week follow-up

    Changes in body fat percentage from baseline to 12-week follow-up. The participant had their body fat percentage measured using bioimpedance analyses (InBody 770 analyser, InBody Japan, Tokyo, Japan). With bare feet, the participants are instructed to stand with heel and forefoot placed on the metal plates of the instrument and grab the handle. A sub-threshold electrical current is then transmitted through the body from foot to foot. The impedance-based body fat percentage is determined as per the manufacturer's imbedded equations

Sponsors and collaborators

Lead sponsor

Xiangya Hospital of Central South University

Other

Registry information

Official study title

Effect of a Village Doctor-delivered Exercise Therapy for Knee Osteoarthritis: a Pilot Feasibility Study

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jun 10, 2026
Registry last updated
Jun 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.